Matthew Gil, MSc

National Health Service
Glasgow, Glasgow

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 1052 - Predicting Pulmonary Toxicity in Lung Cancer Patients with Interstitial Lung Disease Receiving SABR Using Machine Learning: A Secondary Analysis of ASPIRE-ILD

  Tuesday, October 1, 2024
  2:55 PM – 3:00 PM ET